Renalytix (Reg S) (RENX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

6.58p
   
  • Change Today:
    -0.67p
  • 52 Week High: 12.50
  • 52 Week Low: 5.62
  • Currency: UK Pounds
  • Shares Issued: 437.02m
  • Volume: 711,670
  • Market Cap: £28.76m
  • RiskGrade: 348
  • Beta: 0.59

Latest Deals

Traded Action Notifier PriceAmountValue
26-Sep-25 Placing Robert (Rob) Graham Naylor 9.50p 105,263 £9,999.98
26-Sep-25 Placing Catherine Coste 9.50p 105,263 £9,999.98
26-Sep-25 Placing Christopher H B Mills 9.50p 2,500,000 £237,500.00
10-Dec-24 Buy James Renwick McCullough 8.50p 25,000 £2,125.00
05-Dec-24 Buy Christopher H B Mills 7.00p 48,601 £3,402.07

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
26-Sep-25 Placing Christopher H B Mills 9.50p 2,500,000 £237,500.00
26-Sep-25 Placing Catherine Coste 9.50p 105,263 £9,999.98
26-Sep-25 Placing Robert (Rob) Graham Naylor 9.50p 105,263 £9,999.98
05-Dec-24 Buy James Renwick McCullough 7.50p 53,300 £3,997.50
05-Dec-24 Buy Christopher H B Mills 7.00p 48,601 £3,402.07

Director Shareholdings

Notifier Holding Value*
Christopher H B Mills 17,061,345 £1,122,636
James Renwick McCullough 3,242,096 £213,330
Robert (Rob) Graham Naylor 693,318 £45,620
Fergus Fleming 569,481 £37,472
Catherine Coste 385,129 £25,342

Major Shareholders

Notifier** Holding Value*
Heights Capital Management, Inc. 43,151,533 £2,839,371
UBS Group AG 34,900,846 £2,296,476
CVI Holdings, LLC 33,000,000 £2,171,400
Ruffer LLP 28,500,000 £1,875,300
Unicorn Asset Management Limited 25,797,882 £1,697,501
UBS Group AG 22,590,196 £1,486,435
Harwood Capital LLP 17,061,345 £1,122,636
Harwood Capital LLP 14,609,946 £961,334
Polar Capital, LLP 13,196,197 £868,310
Icahn School of Medicine at Mount Sinai 10,750,926 £707,411
Jefferson River Capital LLC 8,294,932 £545,806
Mount Sinai 8,018,986 £527,649
Gilder Gagnon Howe and Co LLC 6,042,634 £397,605
Forest Nominees Limited 4,001,187 £263,278
Lombard Odier & Co Ltd 2,952,334 £194,264
Amati Global Investors 2,455,247 £161,555
Fidelity Investment International 2,173,851 £143,039

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

RENX Market Data

Currency UK Pounds
Share Price 6.58p
Change Today -0.67p
% Change -9.24 %
52 Week High 12.50
52 Week Low 5.62
Volume 711,670
Shares Issued 437.02m
Market Cap £28.76m
Beta 0.59
RiskGrade 348

RENX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

RENX Dividends

No dividends found

Trades for 06-Nov-2025

Time Volume / Share Price
10:41 14,492 @ 6.90p
10:33 58,355 @ 6.87p
10:19 50,000 @ 6.87p
10:11 80,000 @ 6.80p
10:08 44,190 @ 6.87p

RENX Key Personnel

CEO James Renwick McCullough

Top of Page